{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:24:36Z","timestamp":1791815076836,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shanxi Cancer Hospital, Cancer Hospital,Chinese Academy of Medical Sciences,Shanxi Hospital, doctoral master's guide and companion flying Fund","award":["SD2023010"],"award-info":[{"award-number":["SD2023010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01431-y","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:44:04Z","timestamp":1785408244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Colorectal cancer-derived exosomal ETS2 promotes macrophage M2 polarization by transcriptionally activating PRPF4"],"prefix":"10.1007","volume":"39","author":[{"given":"Dengfeng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000543921","volume":"106","author":"T Matsuda","year":"2025","unstructured":"Matsuda T, Fujimoto A, Igarashi Y. Colorectal cancer: epidemiology, risk factors, and public health strategies. Digestion. 2025;106:91\u20139.","journal-title":"Digestion"},{"key":"1431_CR2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423077122","volume":"122","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zuo A, Ba Y, et al. Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activation. Proc Natl Acad Sci U S A. 2025;122:e2423077122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1431_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115809","volume":"230","author":"AH \u00d6nder","year":"2025","unstructured":"\u00d6nder AH, \u00c7atli MM. Colorectal cancer treatment commentary review. Eur J Cancer. 2025;230:115809.","journal-title":"Eur J Cancer"},{"key":"1431_CR4","first-page":"250","volume":"68","author":"AMD Wolf","year":"2018","unstructured":"Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250\u201381.","journal-title":"CA Cancer J Clin"},{"key":"1431_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41571-021-00495-z","volume":"18","author":"F Di Nicolantonio","year":"2021","unstructured":"Di Nicolantonio F, Vitiello PP, Marsoni S, et al. Precision oncology in metastatic colorectal cancer\u2014from biology to medicine. Nat Rev Clin Oncol. 2021;18:506\u201325.","journal-title":"Nat Rev Clin Oncol"},{"key":"1431_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100049","volume":"22","author":"F Mou","year":"2025","unstructured":"Mou F, Sun Q, Ye Z. Advances in the combination of immunotherapy and radiotherapy for microsatellite-stable metastatic colorectal cancer. Curr Proteomics. 2025;22:100049.","journal-title":"Curr Proteomics"},{"key":"1431_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.972258","volume":"9","author":"L Maoxi","year":"2022","unstructured":"Maoxi L, Xingyu G, Wenqi B, Bo J. Application of the natural orifice specimen extraction surgery I-type E method combined with 3D laparoscopy in sphincter-preserving surgery of low rectal cancer. Front Surg. 2022;9:972258.","journal-title":"Front Surg"},{"key":"1431_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/cac2.70047","volume":"45","author":"Y Zhan","year":"2025","unstructured":"Zhan Y, Xu J, Zhang Z, et al. Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer liver metastasis. Cancer Commun (Lond). 2025;45:1203\u201328.","journal-title":"Cancer Commun (Lond)"},{"key":"1431_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7150\/thno.101001","volume":"15","author":"A Deng","year":"2025","unstructured":"Deng A, Fan R, Hai Y, et al. A STING agonist prodrug reprograms tumor-associated macrophage to boost colorectal cancer immunotherapy. Theranostics. 2025;15:277\u201399.","journal-title":"Theranostics"},{"key":"1431_CR10","doi-asserted-by":"publisher","first-page":"1714954","DOI":"10.3389\/fimmu.2025.1714954","volume":"16","author":"Y Duan","year":"2025","unstructured":"Duan Y, Li A, Miao D, et al. Colorectal cancer stem cells crosstalk in tumor immune microenvironment and targeted therapeutic strategies. Front Immunol. 2025;16:1714954.","journal-title":"Front Immunol"},{"key":"1431_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 2021;11:933\u201359.","journal-title":"Cancer Discov"},{"key":"1431_CR12","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201908224","author":"KB Nguyen","year":"2020","unstructured":"Nguyen KB, Spranger S. Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling. J Cell Biol. 2020. https:\/\/doi.org\/10.1083\/jcb.201908224.","journal-title":"J Cell Biol"},{"key":"1431_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1084\/jem.20150295","volume":"212","author":"A Mantovani","year":"2015","unstructured":"Mantovani A, Allavena P. The interaction of anticancer therapies with tumor-associated macrophages. J Exp Med. 2015;212:435\u201345.","journal-title":"J Exp Med"},{"key":"1431_CR14","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41423-024-01232-z","volume":"21","author":"J Kzhyshkowska","year":"2024","unstructured":"Kzhyshkowska J, Shen J, Larionova I. Targeting of TAMs: can we be more clever than cancer cells? Cell Mol Immunol. 2024;21:1376\u2013409.","journal-title":"Cell Mol Immunol"},{"key":"1431_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/2326-6066.CIR-20-0527","volume":"9","author":"JP V\u00e4yrynen","year":"2021","unstructured":"V\u00e4yrynen JP, Haruki K, Lau MC, et al. The prognostic role of macrophage polarization in the colorectal cancer microenvironment. Cancer Immunol Res. 2021;9:8\u201319.","journal-title":"Cancer Immunol Res"},{"key":"1431_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6:75.","journal-title":"Signal Transduct Target Ther"},{"key":"1431_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang Q, Xu M, et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer. 2020;19:41.","journal-title":"Mol Cancer"},{"key":"1431_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13046-024-03269-4","volume":"44","author":"Z Ye","year":"2025","unstructured":"Ye Z, Yi J, Jiang X, et al. Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression. J Exp Clin Cancer Res. 2025;44:2.","journal-title":"J Exp Clin Cancer Res"},{"key":"1431_CR19","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.7150\/ijbs.114222","volume":"21","author":"Y Li","year":"2025","unstructured":"Li Y, You J, Zou Z, et al. Decoding the tumor microenvironment: exosome-mediated macrophage polarization and therapeutic frontiers. Int J Biol Sci. 2025;21:4187\u2013214.","journal-title":"Int J Biol Sci"},{"key":"1431_CR20","doi-asserted-by":"publisher","first-page":"107327482514066","DOI":"10.1177\/10732748251406674","volume":"32","author":"X Fu","year":"2025","unstructured":"Fu X, Pang M, Wang Z, Wang H. Macrophage polarization in the tumor microenvironment of hepatocellular carcinoma: from mechanistic insights to translational therapies. Cancer Control. 2025;32:10732748251406674.","journal-title":"Cancer Control"},{"key":"1431_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2174\/0113892029358348250124064940","volume":"26","author":"G Haimei","year":"2025","unstructured":"Haimei G, Hui Y, Jiao C, et al. YY2 serves as a novel prognostic biomarker correlated with immune microenvironment and glycolysis in esophageal carcinoma. Curr Genomics. 2025;26:312\u201328.","journal-title":"Curr Genomics"},{"key":"1431_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2147\/IJN.S502363","volume":"20","author":"Y Li","year":"2025","unstructured":"Li Y, Yang Q, Li D, Li W, Men W. Exosomes: key messengers mediating the interaction between tumor cells and CD8(+) T Cells in the tumor microenvironment. Int J Nanomed. 2025;20:653\u201367.","journal-title":"Int J Nanomed"},{"key":"1431_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8:237\u201355.","journal-title":"Theranostics"},{"key":"1431_CR24","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1007\/s12094-022-02877-w","volume":"24","author":"YH Wan","year":"2022","unstructured":"Wan YH, Liu QS, Wan SS, Wang RW. Colorectal cancer-derived exosomes and modulation KRAS signaling. Clin Transl Oncol. 2022;24:2074\u201380.","journal-title":"Clin Transl Oncol"},{"key":"1431_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41419-022-04506-4","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Wang XY, Zhang P, et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death Dis. 2022;13:57.","journal-title":"Cell Death Dis"},{"key":"1431_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0328881","volume":"20","author":"T Shu","year":"2025","unstructured":"Shu T, Wu X, Wei C, et al. ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway. PLoS ONE. 2025;20:e0328881.","journal-title":"PLoS ONE"},{"key":"1431_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189368","volume":"1880","author":"S John","year":"2025","unstructured":"John S, Kalathil D, Pothuraju R, Nair SA. Deciphering ETS2: an indispensable conduit to cancer. Biochim Biophys Acta (BBA) - Rev Cancer. 2025;1880:189368.","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"1431_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05513-1","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ying Y, Wang M, et al. A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell Death Dis. 2023;14:8.","journal-title":"Cell Death Dis"},{"key":"1431_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2019.101440","volume":"47","author":"S Park","year":"2019","unstructured":"Park S, Han SH, Kim HG, et al. PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway. Mol Cell Probes. 2019;47:101440.","journal-title":"Mol Cell Probes"},{"key":"1431_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.21873\/anticanres.17443","volume":"45","author":"W Kim","year":"2025","unstructured":"Kim W, Park S, Han SH, et al. PRPF4 knockdown suppresses glioblastoma progression via the p38 MAPK and ERK signaling pathways. Anticancer Res. 2025;45:549\u201364.","journal-title":"Anticancer Res"},{"key":"1431_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14431-2","volume":"25","author":"N Li","year":"2025","unstructured":"Li N, Gao LJ, Guo KX, et al. NHP2 and PRPF4 are hub genes associated with the prognosis of colorectal cancer. BMC Cancer. 2025;25:1088.","journal-title":"BMC Cancer"},{"key":"1431_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008491","author":"Z Sun","year":"2024","unstructured":"Sun Z, Xu Y, Shao B, et al. Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10\/STAT3 axis in a colorectal cancer model. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2023-008491.","journal-title":"J Immunother Cancer"},{"key":"1431_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00991-2","volume":"13","author":"S Zhao","year":"2020","unstructured":"Zhao S, Mi Y, Guan B, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. J Hematol Oncol. 2020;13:156.","journal-title":"J Hematol Oncol"},{"key":"1431_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41392-025-02518-y","volume":"10","author":"W Li","year":"2025","unstructured":"Li W, Liang L, Liu S, et al. Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression. Signal Transduct Target Ther. 2025;10:420.","journal-title":"Signal Transduct Target Ther"},{"key":"1431_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156766","volume":"142","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, Du Y, Jiang H, et al. KAJF alleviated colorectal cancer liver metastasis by reshaping the gut microbiota and inhibiting M2-like macrophage polarization. Phytomedicine. 2025;142:156766.","journal-title":"Phytomedicine"},{"key":"1431_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309298","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang J, Shi H, et al. M2 tumor-associated macrophages-derived exosomal MALAT1 promotes glycolysis and gastric cancer progression. Adv Sci (Weinh). 2024;11:e2309298.","journal-title":"Adv Sci (Weinh)"},{"key":"1431_CR37","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.7150\/ijbs.94440","volume":"20","author":"Y Hu","year":"2024","unstructured":"Hu Y, Li Y, Xiong H, et al. Exosomal SLC16A1-AS1-induced M2 macrophages polarization facilitates hepatocellular carcinoma progression. Int J Biol Sci. 2024;20:4341\u201363.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"1431_CR38","first-page":"10","volume":"2","author":"EA Fry","year":"2018","unstructured":"Fry EA, Inoue K. Aberrant expression of ETS1 and ETS2 proteins in cancer. Cancer Rep Rev. 2018;2(3):10\u20135761.","journal-title":"Cancer Rep Rev"},{"key":"1431_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.neo.2016.07.006","volume":"18","author":"JR Pitarresi","year":"2016","unstructured":"Pitarresi JR, Liu X, Sharma SM, et al. Stromal ETS2 regulates chemokine production and immune cell recruitment during acinar-to-ductal metaplasia. Neoplasia. 2016;18:541\u201352.","journal-title":"Neoplasia"},{"key":"1431_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39\u201351.","journal-title":"Cell"},{"key":"1431_CR41","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","volume":"22","author":"T Hu","year":"2016","unstructured":"Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol. 2016;22:6876\u201389.","journal-title":"World J Gastroenterol"},{"key":"1431_CR42","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1042\/CS20191174","volume":"134","author":"H Wang","year":"2020","unstructured":"Wang H, Huang R, Guo W, et al. RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer. Clin Sci (Lond). 2020;134:1973\u201390.","journal-title":"Clin Sci (Lond)"},{"key":"1431_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaf242","author":"Z Guo","year":"2025","unstructured":"Guo Z, Li L, Luo J, et al. The Ets2 super-enhancer modulates endothelial-mesenchymal transition during cardiac aging. Cardiovasc Res. 2025. https:\/\/doi.org\/10.1093\/cvr\/cvaf242.","journal-title":"Cardiovasc Res"},{"key":"1431_CR44","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41374-019-0331-9","volume":"100","author":"F Yao","year":"2020","unstructured":"Yao F, Wang X, Cui ZK, et al. ETS2 promotes epithelial-to-mesenchymal transition in renal fibrosis by targeting JUNB transcription. Lab Invest. 2020;100:438\u201353.","journal-title":"Lab Invest"},{"key":"1431_CR45","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/cbf.3437","volume":"37","author":"S Park","year":"2019","unstructured":"Park S, Han SH, Kim HG, et al. Suppression of PRPF4 regulates pluripotency, proliferation, and differentiation in mouse embryonic stem cells. Cell Biochem Funct. 2019;37:608\u201317.","journal-title":"Cell Biochem Funct"},{"key":"1431_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00976-1","volume":"13","author":"X Zhou","year":"2020","unstructured":"Zhou X, Zhan L, Huang K, Wang X. The functions and clinical significance of circRNAs in hematological malignancies. J Hematol Oncol. 2020;13:138.","journal-title":"J Hematol Oncol"},{"key":"1431_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1158\/0008-5472.CAN-09-1688","volume":"70","author":"O Ashiru","year":"2010","unstructured":"Ashiru O, Boutet P, Fern\u00e1ndez-Messina L, et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res. 2010;70:481\u20139.","journal-title":"Cancer Res"},{"key":"1431_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0625-1","volume":"11","author":"S Wang","year":"2018","unstructured":"Wang S, Xu M, Li X, et al. Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties. J Hematol Oncol. 2018;11:82.","journal-title":"J Hematol Oncol"},{"key":"1431_CR49","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey SM, Zhang F, Ding C, et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021;33:2040-2058.e2010.","journal-title":"Cell Metab"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01431-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:06:04Z","timestamp":1785452764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01431-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01431-y","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no financial or non-financial conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Cancer Hospital Affiliated to Shanxi Medical University. All procedures involving human colorectal cancer tissue samples complied with the Declaration of Helsinki and its subsequent amendments. Written informed consent was obtained from all patients before sample collection. All tissue specimens were fully anonymized to protect patient privacy. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Cancer Hospital Affiliated to Shanxi Medical University. The animal study strictly followed the ARRIVE guidelines and the 3Rs principle. All surgical procedures were performed under anesthesia, and every effort was made to minimize animal pain and suffering. Humane euthanasia was conducted at the end of experiments in accordance with national animal welfare regulations.","order":2,"name":"Ethics","label":"Research involving human participants and\/or animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"118"}}